Gliclazide is an oral anti-diabetic who is classified as a sulfonylurea. Gliclazide increases the amount of insulin released pancreas and helps the body use insulin more efficiently.
Indications:
To treat diabetes mellitus type 2 (non-insulin dependent).
Dosage:
The release of regular:
The initial dose: 40-80 mg by mouth (orally), 1-2 times daily.
Increase dose based on patient reaction.
Dose> 160 mg / day should be divided into 2 times a day.
Maximum Dose: 320 mg / day
Extended release:
The initial dose: 30 mg by mouth (orally), 1 times daily.
Increase dose with an increase of 30 mg at a distance of 2-4 weeks, based on the patient’s reaction.
Usual dose: 30-120 mg by mouth (orally), 1 times daily.
Implementation:
Give at breakfast.
Side Effects:
Hypoglycemia, allergic reactions, weight, dose-related increase in GI.
It may encourage the emergence of adverse GI reactions.
Special Instructions:
Use with caution in patients with kidney or liver failure.
Should not be used in case of DKA, major surgery, severe infection, stress or trauma, allergic to sulfur.
No comments:
Post a Comment